Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Публічне Акціонерне Товариство "Київмедпрепарат", Публічне Акціонерне Товариство "Галичфарм"filedCriticalПублічне Акціонерне Товариство "Київмедпрепарат"
Priority to UAA201506803ApriorityCriticalpatent/UA111566C2/en
Publication of UA111566C2publicationCriticalpatent/UA111566C2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Abstract
The invention relates to the pharmaceutical composition of extended release containing the active ingredient and at least one matrix-forming polymer agent selected from polyethylene oxide with molecular weight in the range of 100,000 to 10,000,000 Daltons and hydroxypropyl methylcellulose with nominal viscosity in the range of 3 to 100,000 mPa • s, in combination with one or more pharmaceutically acceptable excipients, and the active ingredient represents morpholine salt of thionitric acid with particle size less than 500 microns, and the active ingredient and matrix-forming polymer agent contained at a 1:0.2-1.9 ratio.
UAA201506803A2015-07-092015-07-09Pharmaceutical composition of extended release of morpholinium [(5-methyl-1h-1,2,4-triasol-3-yl)thio]acetate
UA111566C2
(en)
COMPOSITION, METHOD OF MANUFACTURE OF A TABLET, TABLET, UNIT DOSAGE FORM, ARTICLE OF MANUFACTURE, AND, USE OF A COMPOSITION, TABLET OR UNIT DOSAGE FORM